T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

Clinical trial NCT06045767 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06045767
Sponsor: Ari Raphael
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Metastatic

Start date: 2024-06-01
Primary completion: 2029-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.